Given the non-canonical functions that SmD2 intersected with, we next investigated if its expression level predicts the utility of currently available anti-tumor drug applications by using public resources from the Genomics of Drug Sensitivity in Cancer (GDSC) database (https://www.cancerrxgene.org (accessed on 11 April 2024)) [20]. This evidence concerns the gene SNRPD2 and neoplasm.